3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium

146produits homologués
1 monographie
Capsule, Capsule, hard, Powder for solution +2

Monographies de Santé Canada

1
Nicotinamide Mononucleotide
Oral

Allégations santé approuvées

15
  • Source of (an) antioxidant(s)/Provides (an) antioxidant(s) 2
  • Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals 2
  • A factor in the maintenance of good health
  • A factor in normal growth and development
  • Supports biological functions which play a key role in the maintenance of good health
  • Helps normal growth and development
  • Helps in energy metabolism/(and) tissue formation
  • Helps (to) maintain/support the body's ability to metabolize nutrients 3
  • NMN is a NAD+ precursor which is a factor in normal growth and development
  • NMN is a NAD+ precursor which helps to support biological functions which play a key role in the maintenance of good health
  • NMN is a NAD+ precursor which is an important cofactor in energy metabolism
  • 1 NMN is a vitamin B3 derivative and therefore uses associated with vitamin B3 as per the Multi-vitamin/mineral Supplements Monograph are acceptable
  • 2 If NMN is combined with other medicinal ingredients with antioxidant properties, there is an option to use the antioxidant claims in plural. The singular should be used when the product only contains one chemical substance (e.g., NMN) as the medicinal ingredient associated with the antioxidant claim
  • 3 This claim is not intended to convey that taking these vitamins helps to boost metabolism, upregulate a bodily system and/or directly convert food to energy. Inferring such claims would be misleading and is not permitted. In order to avoid any misinterpretation of this claim, the terms 'carbohydrates, fats, proteins, etc.' must not be used to further specify the term 'nutrients'
  • The above uses can be combined on the product label (e.g., Source of an antioxidant and helps normal growth and development)

Plages de doses approuvées

1
PopulationPlage de dosesFréquence
Adults 18 years and older3–1200 milligramsper day

Mises en garde et contre-indications

2
cautionAsk a healthcare practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
cautionAsk a healthcare practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Yoshino et al. 2021).

Noms alternatifs

3
NMN(common)Nicotinamide mononucleotide(common)3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium

Quantités courantes dans les produits homologués

10
250 mg50 produits homologués
300 mg40 produits homologués
500 mg37 produits homologués
200 mg23 produits homologués
150 mg17 produits homologués
600 mg16 produits homologués
125 mg5 produits homologués
350 mg4 produits homologués
37.5 mg2 produits homologués
100 mg2 produits homologués

Ingrédients connexes

8
Nicotinamide MononucleotideCovers this ingredientNMNShared monographNicotinamide MononucleotideShared monographtrans-ResveratrolCo-occurs in 20 productsCholecalciferolShared health claimsErgocalciferolShared health claimsVitamin DShared health claimsVitamin D2Shared health claims

Vérifiez la conformité de votre produit contenant 3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium

Validez votre formulation contre les monographies de Santé Canada et 146 produits homologués contenant 3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium.

Analyser gratuitement